MD, Mount Sinai School of Medicine
BS, Yale University

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Manning AT, Eaton A, Azu M, Sampson M, Patil S, Godfrey D, Beesen AA, Liberman L, Gemignani ML. Breast cancer screening at the Breast Examination Center of Harlem. Ann Surg Oncol. 2015; 22(6):2026-33. PMID: 25448800; PMCID: PMC4426244; DOI: 10.1245/s10434-014-4240-2;
  2. Taylor DM, Moser R, Régulier E, Breuillaud L, Dixon M, Beesen AA, Elliston L, Silva Santos Mde F, Kim J, Jones L, Goldstein DR, Ferrante RJ, Luthi-Carter R. MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. J Neurosci. 2013 Feb 6; 33(6):2313-25. PMID: 23392662; PMCID: PMC3711389; DOI: 10.1523/JNEUROSCI.4965-11.2013;
  3. Rudinskiy N, Kaneko YA, Beesen AA, Gokce O, Régulier E, Déglon N, Luthi-Carter R. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. J Neurochem. 2009 Oct; 111(2):460-72. PMID: 19686238; DOI: 10.1111/j.1471-4159.2009.06344.x;
  4. Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci. 2003 Oct 15; 23(28):9418-27.View Related Profiles. PMID: 14561870

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Contact for Mentoring: